1. Patient arrival at the hospital within 3 hours of symptom onset:
Timely arrival allows for a broader window of opportunity to administer clot-dissolving medication.
2. Rapid assessment of the patient's neurological status:
Evaluating symptoms like facial drooping, arm weakness, and speech difficulties aids in diagnosis.
3. Documentation of the exact time when symptoms started:
Precise timing is crucial to determine eligibility for thrombolytic treatment.
4. Confirmation of the type of stroke (Ischemic or Hemorrhagic):
This helps determine whether thrombolytic therapy is appropriate.
5. Blood pressure monitoring and management:
Controlling blood pressure levels is essential to minimize the risk of bleeding during treatment.
6. Laboratory tests, including coagulation studies and blood glucose levels:
These tests ensure that patients meet the criteria for fibrinolytic therapy.
7. Administering a thrombolytic agent (such as alteplase) within the recommended time frame:
This medication dissolves clots in the brain's blood vessels, restoring blood flow.
8. Monitoring for potential complications during and after treatment:
Vigilance is necessary to address any adverse reactions or complications.
9. Timely imaging studies (CT scan or MRI) to assess the extent of brain damage:
Imaging helps assess the stroke's severity and guides further treatment decisions.
10. Communication with stroke specialists and potential transfer for advanced care if necessary:
Collaboration with experts ensures the best possible care for stroke patients.
